Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, <i>EGFR</i> –Mutant, Metastatic Nonsquamous Non–Small Cell Lung CancerJames Chih‐Hsin Yang, Gongyan Chen, Dae Ho Lee et al.|Journal of Clinical Oncology|2024Cited by 154
The EORTC 10041/BIG 03-04 MINDACT trial is feasible: Results of the pilot phaseEmiel J. Rutgers, Fátima Cardoso, Martine Piccart et al.|European Journal of Cancer|2011Cited by 105
Protocol for the development of a core outcome set and reporting guidelines for locoregional treatment in neoadjuvant systemic breast cancer treatment trials: the PRECEDENT projectShelley Potter, Stuart McIntosh, Kerry Avery et al.|BMJ Open|2024Cited by 12
Exploring locoregional treatment reporting in neoadjuvant systemic breast cancer treatment studies: A systematic reviewMichael Jiang, Shelley Potter, Kerry Avery et al.|European Journal of Surgical Oncology|2024Cited by 2
Setting a precedent: Development of a core outcome set for locoregional treatment outcome reporting in neoadjuvant breast cancer trials.Stuart McIntosh, Shelley Potter, Peter Dubsky et al.|Journal of Clinical Oncology|2025Cited by 1